Vanda Pharmaceuticals (VNDA) Q2 2023 Earnings

27JulConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.13
-0.05
0.04
0.12

Details

Expected EPS
-0.13
Actual EPS
0.03
Surprise EPS
0.16
Surprise Percent
+123.08%

Description

Vanda Pharmaceuticals (VNDA) has reported earnings of 0.03 per share for Q2 2023.

0 Comments

Share your thoughts